Home
Stock Market News
Market Sentiment
Trending Industries
Blogs
Contact us
Roche secures CE mark for ovarian cancer detection test
Roche's VENTANA FOLR1 RxDx Assay has received CE mark approval for identifying epithelial ovarian cancer patients suitable for AbbVie's ELAHERE therapy.